ID   SMC-L001
AC   CVCL_X018
DR   cancercelllines; CVCL_X018
DR   Cosmic; 2563250
DR   Wikidata; Q54954940
RX   PubMed=24569940;
CC   Population: Korean.
CC   Doubling time: 70 hours (PubMed=24569940).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=24569940).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=24569940).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=24569940
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 18,24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
RX   PubMed=24569940; DOI=10.1007/s11626-014-9736-3;
RA   Choi S.-J., Lee H., Choe C., Shin Y.-S., Lee J., Moon S.-H., Kim J.;
RT   "Establishment and characterization of a lung cancer cell line,
RT   SMC-L001, from a lung adenocarcinoma.";
RL   In Vitro Cell. Dev. Biol. Anim. 50:519-526(2014).
//